Clinical Trials Directory

Trials / Unknown

UnknownNCT04754503

Survival and Quality of Life After Liver Transplantation in Patients Aged 65 and Over

Status
Unknown
Phase
Study type
Observational
Enrollment
125 (estimated)
Sponsor
Gérond'if · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The main objective of this non-interventional, single-center study is to assess survival and associated factors at 1 year in patients aged 65 and over who received liver transplantation

Detailed description

The expected benefits of this study are to identify the preoperative risk factors of mortality from liver transplant failure in patients aged 65 and over (90-day mortality and 1 and 3-year survival) will allow better selection. candidates for this age group. In the current context of organ shortage, this study should make it possible to reduce the number of risky transplants and thus improve the allocation of grafts.Inclusion of patients who meet the inclusion criteria will be carried out during their hospitalization in the surgical department of the hepato-bilary center. Included patients will receive a standardized geriatric assessment in addition to the usual assessment for a liver transplant. The geriatric assessment will be carried out and conducted as follows: geriatric scores and quality of life questionnaires. Two geriatricians will perform the physical examination and blindly estimate each other's probability of survival at 90 days using a Likert scale. Geriatricians will be blinded to hepatic data (reasons for transplantation). The consultation as well as the completion of the questionnaire will be carried out during the pre-transplantation assessment. Survival and quality of life will be assessed at 3 and 12 months post-transplantaion.

Conditions

Timeline

Start date
2021-04-09
Primary completion
2024-04-01
Completion
2025-04-01
First posted
2021-02-15
Last updated
2023-01-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04754503. Inclusion in this directory is not an endorsement.